Literature DB >> 15946313

Pericardial graft vs. host disease in a patient with myelodysplastic syndrome following peripheral blood stem cell transplantation.

Yasuyuki Saito1, Takafumi Matsushima, Noriko Doki, Yuki Tsumita, Makiko Takizawa, Akihiko Yokohama, Hiroshi Handa, Norifumi Tsukamoto, Masamitsu Karasawa, Hirokazu Murakami, Yoshihisa Nojima.   

Abstract

A patient with myelodysplastic syndrome developed pericardial effusion 20 month after allogenic peripheral blood stem cell transplantation. Sclerotic and erythematous skin lesions were observed over the face and extremities, and a diagnosis of chronic graft vs. host disease (GVHD) was made based on skin biopsy findings. Pericardial fluid contained numerous CD8+/HLA-DR+ lymphocytes, but no leukaemic cells. Tumour necrosis factor alpha (TNFalpha) and soluble Fas (sFas) levels were highly elevated in both the effusion and serum. The patient was treated with methylprednisolone and tacrolimus. Skin GVHD improved rapidly associated with resolution of pericardial effusion and reductions in cytokine levels. We concluded that pericardial effusion was due to pericarditis and was a manifestation of chronic GVHD in this patient, and that cytotoxic lymphocytes and specific cytokines played significant roles. (c) Blackwell Munksgaard 2005.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15946313     DOI: 10.1111/j.1600-0609.2005.00425.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  2 in total

1.  Pleuropericarditis, obliterative bronchiolitis and lymphocytic interstitial pneumonitis after allogeneic haematopoietic stem cell transplantation.

Authors:  Amin Alousi; Somnath Ghosh; David Rice; Cesar Moran; John T Manning; Cesar Iliescu; Sharon Hymes; Stella Kim; Lara Bashoura; Steven Kornblau; Burton F Dickey
Journal:  BMJ Case Rep       Date:  2011-02-23

2.  Factors Affecting Survival in Children With Pericardial Effusion After Hematopoietic Stem Cell Transplantation.

Authors:  Tang-Her Jaing; Shih-Hsiang Chen; Yu-Chuan Wen; Tsung-Yen Chang; Dai-Yun Tsai; Hung-Tao Chung; Pei-Kwei Tsay
Journal:  Cell Transplant       Date:  2017-11       Impact factor: 4.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.